Federal drug officials are aiming to significantly reduce the timeline for new drug development by launching real-time ...
The FDA’s new draft guidance on Bayesian methods in clinical trials has been hailed by some as a breakthrough that could speed drug development. But statisticians and researchers are divided on ...
Clinical trials in China are getting attention at an international oncology gathering in Chicago. China’s surging biotechnology industry is fueling alarm that U.S. dominance in the field is waning.
Companies see a commercial opportunity in creating new ways to administer drugs to patients – in space.
Megan covers the intersection of science and society. How is biomedical research funded? Who benefits? And how do new technologies reflect and shape our values? You can reach Megan on Signal at ...
A new drug targets RAS cancer-causing cells in the pancreas, nearly doubling survival rates in clinical trials. Here's how ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Modern Medical Research Laboratory. Scientific Lab, Drug Engineering Center Full of ...
After trial flops in spinal muscular atrophy, depression and bipolar disorder—and a costly rare disease drug ...
The GLP-1 PR has been a little too good. Everyone knows the drugs lead to rapid weight loss — including participants in supposedly “blind” drug trials. So now, when those participants don’t drop ...
(Bloomberg) -- The companies developing new weight-loss medicines have a problem: the balance of power has shifted, and patients are bailing out of their clinical trials. People who don’t lose weight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results